{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

This article has been approved by the National Association for Neonatal Nurses Certification Board for Category B credit toward recertification as an NNP.

Purpose of Activity

To present a study designed to improve accuracy and consistency of neonatal withdrawal assessment using Finnegan scores.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Distinguish the use of the Finnegan Neonatal Abstinence Scoring System (Finnegan Scale) and the methodology used to improve nurses' accuracy in using it.
  2. Identify the results of the study and their implications.

Disclosures

The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • KY-BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Planner
Test Code: ANC0218
Published: Feb 2018
Expires: 12/31/2026
Sources: Advances in Neonatal Care
Required Passing Score: 15/17 (88%)
Authors: Wendy Timpson, MD, MEd; Cheryl Killoran, MS, RNC-NIC; Louise Maranda, PhD; Alan Picarillo, MD; Elisabeth Bloch-Salisbury, PhD
Categories: Neonatal , Quality Improvement
Specialties: Neonatal
Topics: Finnegan Scale , Neonatal Abstinence Syndrome , Neonatal Health , Opioids , Substance Withdrawal , Substance-Exposed Infants